Enable Ventures Closes $50M Fund for Disability Tech

Enable Ventures has reached the final close of Enable Ventures Fund I at $50.31M in total commitments. The September 29, 2026 close gives founder and managing partner Regina “Gina” Kline a permanent pool of early-stage capital for companies using disability-inclusive design across worktech, digital health, assistive technology, and artificial intelligence.

The exact accounting matters. The fund-close announcement carries $50.31M in its headline and rounds the total to $50M in the body, while Axios independently described the close as just over $50M. A 2023 SEC filing listed a $75M offering target, but a target is not capital raised and should not be added to the final-close amount.

Enable Ventures is trying to move accessibility upstream. Instead of asking a company to retrofit a product after customers encounter barriers, the firm invests around the premise that disability experience and universal design can expose product requirements, markets, and technical opportunities earlier.

Fund I Reaches Its Final Close

The legal vehicle is Enable Ventures Fund I, L.P., a Delaware limited partnership managed by Enable Ventures Management, LLC. Kline launched the firm in June 2022 alongside Jim Sorenson, and Enable operates within the Sorenson Impact Platform of Funds.

The SEC history shows how the fund developed. Its original Form D named a $75M target, followed by amendments reporting $22.25M sold in November 2023, $25.35M in September 2024, and $34.9M in June 2025. Those filings are progress markers rather than separate funds or rounds; the new announcement is the verified final close.

The limited-partner roster includes UnitedHealth Group, Liberty Mutual Investments, the Ford Foundation, Ally Bank, SHRM, Ascension, Britebound, Weingart Foundation, Social Finance, The Doctors Company, Next50, and Guy’s & St Thomas’ Foundation. Individual commitment sizes, fund economics, reserve policy, and ownership targets were not disclosed.

Disability Inclusion Becomes an Investment Thesis

Enable’s investment approach covers 4 areas: upskilling and reskilling, work-related technology, next-generation assistive technology, and founders with disabilities. The connective tissue is not a single product category. It is the belief that technology designed with disability experience at the center can solve overlooked problems while reaching a broader market.

That framing changes the role of accessibility in product development. A compliance-led process asks whether an existing product meets a standard. An investment-led process asks whether people historically excluded from design, employment, and capital can reveal a better starting point for the product itself.

Kline brings an unusual background to that question. Before venture capital, the Enable Ventures team profile says she spent nearly 15 years as a civil-rights lawyer, including work at the U.S. Department of Justice on employment conditions for workers with disabilities. Her move into venture capital puts the resource-allocation decision, not only the legal remedy, at the center of the strategy.

The Portfolio Is the Test

Enable Ventures says Fund I has made 11 investments. The portfolio includes Be My Eyes, an AI visual interpreter for blind and low-vision users; Kalogon, which develops sensor-enabled seating systems; Cionic, which builds a wearable neural sleeve; DeepWalk, which uses mobile LiDAR and software for sidewalk accessibility; and Inclusively, which helps employers manage accommodations and connect with disability-diverse talent.

The remaining disclosed investments span virtual care, live captioning, employment preparation, disability-benefit navigation, community-health infrastructure, and accessible travel. Axios reports that Enable expects Fund I to make about 25 investments, which means the final close supports a portfolio still in formation rather than a finished proof of the strategy.

The distinction is important. A list of large LPs shows that institutions were willing to underwrite the mandate. It does not establish realized returns, durable adoption, or a repeatable advantage. Those questions now move from fundraising materials into company selection, follow-on support, customer outcomes, and eventual exits.

A Large Market With Persistent Access Gaps

The addressable need is wider than a narrow assistive-device category. The World Health Organization estimates that more than 1.3B people, about 16% of the global population, live with disability. WHO and UNICEF also estimate that more than 2.5B people need assistive products, with the figure expected to exceed 3.5B by 2050.

Employment data shows why Enable’s mandate extends beyond health technology. The International Labour Organization found that people with disabilities participate in labor markets at lower rates and, when employed, earn 12% less per hour on average. Worktech, skills platforms, accessible software, and founder capital all sit inside that economic record.

Specialist funds are increasingly defining venture strategies around a system rather than a conventional software category. Brighteye Ventures’ Fund III first close, for example, widened an education-technology thesis into the infrastructure around learning and work. Enable’s version begins with disability inclusion and asks whether the perspective can surface stronger products across several markets.

What the Close Changes

The final close gives Enable Ventures time and discretion to keep testing a claim that the technology market has usually handled too late: inclusion can be part of invention, not merely a repair. Its institutional LPs have now attached capital to that idea, and the 11-company portfolio has begun turning it into operating evidence.

Fund I will be judged through the companies it selects, the customers they earn, and the value they create for people whose needs were previously treated as edge cases. The close moves Enable beyond proving that a disability-focused venture vehicle can be raised. The work now sits in whether its portfolio can make inclusive design legible as both a product advantage and an investment discipline.